APA (7th ed.) Citation

Loftus, E. V., Feagan, B. G., Panaccione, R., Colombel, J., Sandborn, W. J., Sands, B. E., . . . Vermeire, S. (2020). Long‐term safety of vedolizumab for inflammatory bowel disease. Alimentary pharmacology & therapeutics, 52(8), 1353-1365. https://doi.org/10.1111/apt.16060

Chicago Style (17th ed.) Citation

Loftus, Edward V., et al. "Long‐term Safety of Vedolizumab for Inflammatory Bowel Disease." Alimentary Pharmacology & Therapeutics 52, no. 8 (2020): 1353-1365. https://doi.org/10.1111/apt.16060.

MLA (9th ed.) Citation

Loftus, Edward V., et al. "Long‐term Safety of Vedolizumab for Inflammatory Bowel Disease." Alimentary Pharmacology & Therapeutics, vol. 52, no. 8, 2020, pp. 1353-1365, https://doi.org/10.1111/apt.16060.